Cell Signaling Technology and Alliance Global Group sign an exclusive distribution agreement

Dubai 15th March 2017,

CELL SIGNALING TECHNOLOGIES (USA) signed an exclusive distribution agreement with Alliance Global to bring their highest quality antibody portfolio to AGBL’s market.
“Cell Signaling Technology high-quality, reproducible antibodies will allow scientists in the field of protein and cell biology to optimize their research and save valuable time,” said Fatima Kakal, Product Manager Cell and Molecular Biology Division at Alliance Global Group.

About Cell Signaling Technology
Cell Signaling Technology (CST), head quartered in USA, is a private, family-owned company, founded by scientists and dedicated to providing the world’s highest quality, innovative research and diagnostic products to accelerate biological understanding and enable personalized medicine. In addition to product development and production, CST is also actively engaged in the development of new technologies for signaling analysis as well as mechanistic cell biology research. For more information, please visit www.cellsignal.com

Forward-Looking Statements
All statements in this press release that are not historical are forward-looking statements, including, among other things, statements relating to future uses, quality or performance of, or benefits of using, products or technologies, the expected benefits of the agreement between AGBL and Cell Signaling Technologies and other future events.
AGBL undertakes no obligation to revise or update information in this press release to reflect events or circumstances in the future, even if new information becomes available.